(AOF) – Deutsche Bank has started monitoring Euroapi with a Buy recommendation and a target price of 20 euros. Given the leadership position in structural growth markets and its initiatives to improve its efficiency following its separation from Sanofi last year, the broker believes that the company is well equipped to achieve its growth objective. strong and profitable in the future.
The design office recalls that Euroapi is a world leader in the development, production and marketing of active pharmaceutical ingredients (APIs) – the substances contained in medicines which are responsible for the beneficial effects on health.
The company is aiming for revenue of one billion euros in 2022 and has also entered the fast-growing contract development and manufacturing (CDMO) market for APIs.